Product Overview

i-spero® is a new personalised medicine approach to improve the treatment of depression within primary care.

Product Overview
Product Overview
Product Overview
Optimising the depression treatment pathway
1

Optimising the depression treatment pathway

Sufferers with low mood, anxiety and depression who present in primary care are given access to i‑spero® to complete a simple online test (P1vital® PReDicT Test — CE marked medical device) and objective questionnaires.

Monitor progress
2

Monitor progress

i‑spero® monitors progress against your plan and sends reminders when actions and scheduled assessments are due.

Review outcomes
3

Review outcomes

i‑spero® reviews outcomes against their plan and alerts the patient to take action when needed. The healthcare provider also monitors i‑spero® results and notifications, and can contact the patient in order to discuss recommended changes to their plan.

Monitor outcome assessments
4

Monitor outcome assessments

i‑spero® monitors symptom assessment outcomes on an ongoing basis through to recovery, and can be used to record any plan changes.

Don't just take our word for it
i-spero® helps clinicians to make switches in medication
In recent trials i‑spero® increased the frequency that clinicians switched medication significantly and for all age groups.
i-spero® helps improve compliance with treatment
What I value about i‑spero® is that I can improve the quality of care for my patients. Depression is a huge problem in primary care and proven innovations that can improve outcomes for suffers is to be welcomed.
Patients find the online tests easy to use at home
Over 85% agree that the tests are easy to use’ and over 70% found no technical or connectivity problems when taking the test.
Find out how i-spero® can help your patients

If you are a primary care provider, or are responsible for the purchasing/commissioning of primary care or specialist mental health services we would welcome a discussion.